Martínez-Razo, G.; Pires, P.C.; Domínguez-López, M.L.; Veiga, F.; Vega-López, A.; Paiva-Santos, A.C.
Norcantharidin Nanoemulsion Development, Characterization, and In Vitro Antiproliferation Effect on B16F1 Melanoma Cells. Pharmaceuticals 2023, 16, 501.
https://doi.org/10.3390/ph16040501
AMA Style
Martínez-Razo G, Pires PC, Domínguez-López ML, Veiga F, Vega-López A, Paiva-Santos AC.
Norcantharidin Nanoemulsion Development, Characterization, and In Vitro Antiproliferation Effect on B16F1 Melanoma Cells. Pharmaceuticals. 2023; 16(4):501.
https://doi.org/10.3390/ph16040501
Chicago/Turabian Style
Martínez-Razo, Gabriel, Patrícia C. Pires, María Lilia Domínguez-López, Francisco Veiga, Armando Vega-López, and Ana Cláudia Paiva-Santos.
2023. "Norcantharidin Nanoemulsion Development, Characterization, and In Vitro Antiproliferation Effect on B16F1 Melanoma Cells" Pharmaceuticals 16, no. 4: 501.
https://doi.org/10.3390/ph16040501
APA Style
Martínez-Razo, G., Pires, P. C., Domínguez-López, M. L., Veiga, F., Vega-López, A., & Paiva-Santos, A. C.
(2023). Norcantharidin Nanoemulsion Development, Characterization, and In Vitro Antiproliferation Effect on B16F1 Melanoma Cells. Pharmaceuticals, 16(4), 501.
https://doi.org/10.3390/ph16040501
